Accelerating the Development of Promising Immunotherapies We are proud to present our annual report on BioCanRx’s many achievements in its second full year of operation. The 2016-2017 year marked a number of milestones for our pan-Canadian network. BioCanRx’s strong research program ramped up and funded 16 new projects including an investment to develop clinical Chimeric… Read more »
